Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
about
How can placebo effects best be applied in clinical practice? A narrative reviewAn Integrative Review of the Influence of Expectancies on PainProgressive muscle relaxation reduces migraine frequency and normalizes amplitudes of contingent negative variation (CNV)Preoperative optimization of patient expectations improves long-term outcome in heart surgery patients: results of the randomized controlled PSY-HEART trial.Association between physician beliefs regarding assigned treatment and clinical response: re-analysis of data from the Hypericum Depression Trial Study Group.Ear Acupuncture for Immediate Pain Relief-A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial.Physicians' beliefs about placebo and nocebo effects in antidepressants - an online survey among German practitioners.Placebo improvement in pharmacologic treatment of menopausal hot flashes: time course, duration, and predictorsThe placebo effect in asthma.Harnessing the placebo effect in pediatric migraine clinicCalcitonin gene-related peptide (CGRP): a new target for migraineDistinct neural representations of placebo and nocebo effects.Neuromodulation of conditioned placebo/nocebo in heat pain: anodal vs cathodal transcranial direct current stimulation to the right dorsolateral prefrontal cortex.Complementary and alternative drug therapy versus science-oriented medicine.Response to placebo in clinical epilepsy trials--Old ideas and new insightsDisease Prevention and Health Promotion: How Integrative Medicine Fits.Placebo effects in obesity researchAre open-Label Placebos Ethical? Informed Consent and Ethical EquivocationsComplementary and integrative methods in fibromyalgia.Contextually Aided Recovery (CARe): a scientific theory for innate healing.Patients' Expectations Regarding Medical Treatment: A Critical Review of Concepts and Their AssessmentNocebo vs. placebo: the challenges of trial design in analgesia research.Genetics and the placebo effect: the placebome.Reevaluating the effectiveness of n-back training on transfer through the Bayesian lens: Support for the null.The neuroscience of placebo effects: connecting context, learning and health.Placebo effects and their determinants in gastrointestinal disorders.The Insula: A "Hub of Activity" in Migraine.Role of placebo effects in pain and neuropsychiatric disorders.Coincidental Impact of Transcatheter Patent Foramen Ovale Closure on Migraine with and without Aura - A Comprehensive Meta-Analysis.Effects of Interactions With Animals On Human Psychological Distress.[Placebo response - Mechanisms and clinical applications].Contribution of verbal suggestion to the therapeutic efficacy of an analgesic agent for acute primary headache.Expectancy Effect in Three Mind-Body Clinical Trials.Anti-epileptic drug changes and quality of life in the community.Nocebo effects in clinical studies: hints for pain therapy.Mechanisms of placebo analgesia: A dual-process model informed by insights from cross-species comparisons.Nocebo effects can make you feel pain.Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.Informed Consent: Hints From Placebo and Nocebo Research.
P2860
Q26866497-65971A3B-2344-4B6A-881D-0D6171B0E498Q28072202-C8611173-4BBA-40C2-B056-B46E4C40EF76Q30383280-8261F328-834D-4106-8073-6D55E621A210Q30834455-E022B924-A379-4E89-A312-5FD9EB3A7CFBQ30882051-6CC071E7-56F2-4379-9BBC-A2D9C8FA3012Q33685156-AD2EA496-4905-4EC6-B484-D7D8DD163060Q33730499-74D05527-DB59-4801-9581-8D005AED7F2BQ33746129-EE5D164D-3180-4FCA-97EB-141C8798FFD4Q35097020-28765F36-3FF8-49CE-A3B1-51F61C257907Q35153646-521E4550-5F9E-47E5-AD18-F9578AEB55EDQ35174415-8C08DA2F-7358-4B59-8A96-8305C612A961Q35358428-E3F3D768-7477-4F7F-9C5D-51CF07A2440FQ35533444-9367FA3E-0C55-4171-9049-C3ED7664A756Q35761551-009EE7CC-2360-4B06-A847-7D1E5101D371Q35779270-91A50F56-E96F-4022-AE02-24125DCC479DQ35938221-70B589B5-6055-417B-834C-F66D5FE98C78Q36191041-AD52247A-778A-4E8E-99E6-A595EC9A3313Q36755616-73588656-AAED-4EA3-A953-CB8F9ACE2533Q36971153-565F4DB3-07A3-43C8-BDE2-95BE1EDAD62CQ37269508-73471010-7F5A-4291-952B-D6AB93C6FF3FQ37638301-7ACA1D8E-ACC8-419B-BB7B-DA382FD81AD3Q37653909-F0402BAD-91EF-4250-BAAA-1BF2E541E136Q38351533-11F5122C-6C53-4D2A-B870-37C85CA6A6F9Q38425277-7EA24FEA-3696-4F8B-B208-CAE3373E6705Q38529977-4A68E61E-DF9F-47D5-8F11-568BC7650983Q38531270-AA6EB84B-7432-4A45-BEF1-E48BCC9B663BQ38551120-80C94C16-3AF8-401E-9D38-69FDA2A816ABQ38569987-19871C8D-AC37-4B2D-A638-342813C5C1E5Q38673105-508201A1-8DB6-4DD6-9A3C-697F85ECD04CQ38747848-867BC53D-A181-4E60-85EB-12DB2ED9E5AFQ38799603-E7EF9145-DCF9-41B8-90B6-D2470E936A2FQ39170050-DD94CA8B-D339-4258-87ED-1A339591A386Q39199937-C76B331C-FF51-48F1-B9C6-D0FA8DD0071CQ39704984-EF68D444-C172-4419-B37D-85C0A9C76E09Q41360223-8EBCFD4E-641A-4A0A-BC92-6278D9EDC3F2Q42376620-CE5CB109-DABC-414D-973F-E79F347D490FQ43075563-DB1D54FB-8457-41F2-8601-923FB262566DQ47103163-3D9FCAD7-8C38-4D13-8C3A-6FC86F1790A2Q47724952-9497BF6B-D833-419F-AA04-49BA12844610Q47936334-98A298D2-4696-45E1-B696-1F2370AD4228
P2860
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
@en
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
@nl
type
label
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
@en
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
@nl
prefLabel
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
@en
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
@nl
P2093
P2860
P50
P1476
Altered placebo and drug labeling changes the outcome of episodic migraine attacks.
@en
P2093
David C Hoaglin
John M Kelley
Moshe Jakubowski
Slavenka Kam-Hansen
P2860
P304
P356
10.1126/SCITRANSLMED.3006175
P407
P577
2014-01-01T00:00:00Z